Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
21
NXL Quote, Financials, Valuation and Earnings
Last price:
$0.82
Seasonality move
:
-14.06%
Day range:
$0.80 - $0.84
52-week range:
$0.70 - $3.87
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
77.14x
P/B ratio:
3.15x
Volume:
78.8K
Avg. volume:
143.9K
1-year change:
-72.71%
Market cap:
$15M
Revenue:
$168.7K
EPS (TTM):
-$0.59
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
NXL
Nexalin Technology, Inc.
|
$40K | -$0.12 | 11.11% | -46.83% | $4.00 |
|
ADGM
Adagio Medical Holdings, Inc.
|
-- | -$0.24 | -100% | -91.79% | $4.00 |
|
INBS
Intelligent Bio Solutions, Inc.
|
$1.4M | -- | 160.36% | -- | -- |
|
LAB
Standard BioTools, Inc.
|
$18M | -$0.02 | -60.4% | -72.53% | $1.65 |
|
LNSR
LENSAR, Inc.
|
$17.8M | -$0.08 | 30.98% | -90.51% | $15.00 |
|
MOVE
Movano, Inc.
|
$3.4M | -$7.10 | 76.06% | -41.21% | $30.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
NXL
Nexalin Technology, Inc.
|
$0.81 | $4.00 | $15M | -- | $0.00 | 0% | 77.14x |
|
ADGM
Adagio Medical Holdings, Inc.
|
$0.94 | $4.00 | $19.9M | 218.00x | $0.00 | 0% | 105.21x |
|
INBS
Intelligent Bio Solutions, Inc.
|
$6.99 | -- | $6.7M | -- | $0.00 | 0% | 13.90x |
|
LAB
Standard BioTools, Inc.
|
$1.66 | $1.65 | $638.4M | -- | $0.00 | 0% | 4.88x |
|
LNSR
LENSAR, Inc.
|
$12.01 | $15.00 | $143.5M | -- | $0.00 | 0% | 2.41x |
|
MOVE
Movano, Inc.
|
$7.56 | $30.00 | $6.3M | -- | $0.00 | 0% | 11.44x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
NXL
Nexalin Technology, Inc.
|
-- | 1.626 | -- | 12.20x |
|
ADGM
Adagio Medical Holdings, Inc.
|
106.35% | 2.155 | 73.62% | 0.48x |
|
INBS
Intelligent Bio Solutions, Inc.
|
35.02% | 2.804 | 21.48% | 0.47x |
|
LAB
Standard BioTools, Inc.
|
6.41% | 0.589 | 5.49% | 1.93x |
|
LNSR
LENSAR, Inc.
|
-31.16% | -1.208 | 1.79% | 0.65x |
|
MOVE
Movano, Inc.
|
212.35% | 2.628 | 67.05% | 0.29x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
NXL
Nexalin Technology, Inc.
|
-$436.6K | -$2.3M | -200.06% | -200.06% | -12959.12% | -$1.5M |
|
ADGM
Adagio Medical Holdings, Inc.
|
-$531K | -$5.7M | -193.23% | -340.49% | -- | -$3.5M |
|
INBS
Intelligent Bio Solutions, Inc.
|
$214.9K | -$2.9M | -213.68% | -255.54% | -263.64% | -$2.9M |
|
LAB
Standard BioTools, Inc.
|
$9.5M | -$23.5M | -22.34% | -24.44% | -120.02% | -$23.1M |
|
LNSR
LENSAR, Inc.
|
$5.8M | -$7.6M | -684.94% | -1013.45% | -52.95% | -$3.5M |
|
MOVE
Movano, Inc.
|
-$200K | -$2.6M | -337.24% | -410.28% | -3238.75% | -$1.6M |
Nexalin Technology, Inc. vs. Competitors
-
Which has Higher Returns NXL or ADGM?
Adagio Medical Holdings, Inc. has a net margin of -12576.24% compared to Nexalin Technology, Inc.'s net margin of --. Nexalin Technology, Inc.'s return on equity of -200.06% beat Adagio Medical Holdings, Inc.'s return on equity of -340.49%.
Company Gross Margin Earnings Per Share Invested Capital NXLNexalin Technology, Inc.-2412.16% -$0.13 $4.8M ADGMAdagio Medical Holdings, Inc.-- -$0.66 $20.7M -
What do Analysts Say About NXL or ADGM?
Nexalin Technology, Inc. has a consensus price target of $4.00, signalling upside risk potential of 396.77%. On the other hand Adagio Medical Holdings, Inc. has an analysts' consensus of $4.00 which suggests that it could grow by 325.53%. Given that Nexalin Technology, Inc. has higher upside potential than Adagio Medical Holdings, Inc., analysts believe Nexalin Technology, Inc. is more attractive than Adagio Medical Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings NXLNexalin Technology, Inc.0 0 0 ADGMAdagio Medical Holdings, Inc.1 0 0 -
Is NXL or ADGM More Risky?
Nexalin Technology, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Adagio Medical Holdings, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock NXL or ADGM?
Nexalin Technology, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Adagio Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nexalin Technology, Inc. pays -- of its earnings as a dividend. Adagio Medical Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NXL or ADGM?
Nexalin Technology, Inc. quarterly revenues are $18.1K, which are larger than Adagio Medical Holdings, Inc. quarterly revenues of --. Nexalin Technology, Inc.'s net income of -$2.3M is higher than Adagio Medical Holdings, Inc.'s net income of -$10.1M. Notably, Nexalin Technology, Inc.'s price-to-earnings ratio is -- while Adagio Medical Holdings, Inc.'s PE ratio is 218.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nexalin Technology, Inc. is 77.14x versus 105.21x for Adagio Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NXLNexalin Technology, Inc.77.14x -- $18.1K -$2.3M ADGMAdagio Medical Holdings, Inc.105.21x 218.00x -- -$10.1M
-
Which has Higher Returns NXL or INBS?
Intelligent Bio Solutions, Inc. has a net margin of -12576.24% compared to Nexalin Technology, Inc.'s net margin of -269.38%. Nexalin Technology, Inc.'s return on equity of -200.06% beat Intelligent Bio Solutions, Inc.'s return on equity of -255.54%.
Company Gross Margin Earnings Per Share Invested Capital NXLNexalin Technology, Inc.-2412.16% -$0.13 $4.8M INBSIntelligent Bio Solutions, Inc.19.33% -$0.35 $5.4M -
What do Analysts Say About NXL or INBS?
Nexalin Technology, Inc. has a consensus price target of $4.00, signalling upside risk potential of 396.77%. On the other hand Intelligent Bio Solutions, Inc. has an analysts' consensus of -- which suggests that it could grow by 1616.74%. Given that Intelligent Bio Solutions, Inc. has higher upside potential than Nexalin Technology, Inc., analysts believe Intelligent Bio Solutions, Inc. is more attractive than Nexalin Technology, Inc..
Company Buy Ratings Hold Ratings Sell Ratings NXLNexalin Technology, Inc.0 0 0 INBSIntelligent Bio Solutions, Inc.0 0 0 -
Is NXL or INBS More Risky?
Nexalin Technology, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Intelligent Bio Solutions, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock NXL or INBS?
Nexalin Technology, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Intelligent Bio Solutions, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nexalin Technology, Inc. pays -- of its earnings as a dividend. Intelligent Bio Solutions, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NXL or INBS?
Nexalin Technology, Inc. quarterly revenues are $18.1K, which are smaller than Intelligent Bio Solutions, Inc. quarterly revenues of $1.1M. Nexalin Technology, Inc.'s net income of -$2.3M is higher than Intelligent Bio Solutions, Inc.'s net income of -$3M. Notably, Nexalin Technology, Inc.'s price-to-earnings ratio is -- while Intelligent Bio Solutions, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nexalin Technology, Inc. is 77.14x versus 13.90x for Intelligent Bio Solutions, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NXLNexalin Technology, Inc.77.14x -- $18.1K -$2.3M INBSIntelligent Bio Solutions, Inc.13.90x -- $1.1M -$3M
-
Which has Higher Returns NXL or LAB?
Standard BioTools, Inc. has a net margin of -12576.24% compared to Nexalin Technology, Inc.'s net margin of -162.05%. Nexalin Technology, Inc.'s return on equity of -200.06% beat Standard BioTools, Inc.'s return on equity of -24.44%.
Company Gross Margin Earnings Per Share Invested Capital NXLNexalin Technology, Inc.-2412.16% -$0.13 $4.8M LABStandard BioTools, Inc.48.51% -$0.09 $427M -
What do Analysts Say About NXL or LAB?
Nexalin Technology, Inc. has a consensus price target of $4.00, signalling upside risk potential of 396.77%. On the other hand Standard BioTools, Inc. has an analysts' consensus of $1.65 which suggests that it could fall by -6.63%. Given that Nexalin Technology, Inc. has higher upside potential than Standard BioTools, Inc., analysts believe Nexalin Technology, Inc. is more attractive than Standard BioTools, Inc..
Company Buy Ratings Hold Ratings Sell Ratings NXLNexalin Technology, Inc.0 0 0 LABStandard BioTools, Inc.1 2 0 -
Is NXL or LAB More Risky?
Nexalin Technology, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Standard BioTools, Inc. has a beta of 1.236, suggesting its more volatile than the S&P 500 by 23.585%.
-
Which is a Better Dividend Stock NXL or LAB?
Nexalin Technology, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Standard BioTools, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nexalin Technology, Inc. pays -- of its earnings as a dividend. Standard BioTools, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NXL or LAB?
Nexalin Technology, Inc. quarterly revenues are $18.1K, which are smaller than Standard BioTools, Inc. quarterly revenues of $19.6M. Nexalin Technology, Inc.'s net income of -$2.3M is higher than Standard BioTools, Inc.'s net income of -$31.7M. Notably, Nexalin Technology, Inc.'s price-to-earnings ratio is -- while Standard BioTools, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nexalin Technology, Inc. is 77.14x versus 4.88x for Standard BioTools, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NXLNexalin Technology, Inc.77.14x -- $18.1K -$2.3M LABStandard BioTools, Inc.4.88x -- $19.6M -$31.7M
-
Which has Higher Returns NXL or LNSR?
LENSAR, Inc. has a net margin of -12576.24% compared to Nexalin Technology, Inc.'s net margin of -25.94%. Nexalin Technology, Inc.'s return on equity of -200.06% beat LENSAR, Inc.'s return on equity of -1013.45%.
Company Gross Margin Earnings Per Share Invested Capital NXLNexalin Technology, Inc.-2412.16% -$0.13 $4.8M LNSRLENSAR, Inc.40.56% -$0.31 -$9.2M -
What do Analysts Say About NXL or LNSR?
Nexalin Technology, Inc. has a consensus price target of $4.00, signalling upside risk potential of 396.77%. On the other hand LENSAR, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 24.9%. Given that Nexalin Technology, Inc. has higher upside potential than LENSAR, Inc., analysts believe Nexalin Technology, Inc. is more attractive than LENSAR, Inc..
Company Buy Ratings Hold Ratings Sell Ratings NXLNexalin Technology, Inc.0 0 0 LNSRLENSAR, Inc.0 2 0 -
Is NXL or LNSR More Risky?
Nexalin Technology, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison LENSAR, Inc. has a beta of 0.665, suggesting its less volatile than the S&P 500 by 33.53%.
-
Which is a Better Dividend Stock NXL or LNSR?
Nexalin Technology, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. LENSAR, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nexalin Technology, Inc. pays -- of its earnings as a dividend. LENSAR, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NXL or LNSR?
Nexalin Technology, Inc. quarterly revenues are $18.1K, which are smaller than LENSAR, Inc. quarterly revenues of $14.3M. Nexalin Technology, Inc.'s net income of -$2.3M is higher than LENSAR, Inc.'s net income of -$3.7M. Notably, Nexalin Technology, Inc.'s price-to-earnings ratio is -- while LENSAR, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nexalin Technology, Inc. is 77.14x versus 2.41x for LENSAR, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NXLNexalin Technology, Inc.77.14x -- $18.1K -$2.3M LNSRLENSAR, Inc.2.41x -- $14.3M -$3.7M
-
Which has Higher Returns NXL or MOVE?
Movano, Inc. has a net margin of -12576.24% compared to Nexalin Technology, Inc.'s net margin of -5036.25%. Nexalin Technology, Inc.'s return on equity of -200.06% beat Movano, Inc.'s return on equity of -410.28%.
Company Gross Margin Earnings Per Share Invested Capital NXLNexalin Technology, Inc.-2412.16% -$0.13 $4.8M MOVEMovano, Inc.-250% -$4.73 $1.5M -
What do Analysts Say About NXL or MOVE?
Nexalin Technology, Inc. has a consensus price target of $4.00, signalling upside risk potential of 396.77%. On the other hand Movano, Inc. has an analysts' consensus of $30.00 which suggests that it could grow by 3868.25%. Given that Movano, Inc. has higher upside potential than Nexalin Technology, Inc., analysts believe Movano, Inc. is more attractive than Nexalin Technology, Inc..
Company Buy Ratings Hold Ratings Sell Ratings NXLNexalin Technology, Inc.0 0 0 MOVEMovano, Inc.0 0 0 -
Is NXL or MOVE More Risky?
Nexalin Technology, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Movano, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock NXL or MOVE?
Nexalin Technology, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Movano, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nexalin Technology, Inc. pays -- of its earnings as a dividend. Movano, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NXL or MOVE?
Nexalin Technology, Inc. quarterly revenues are $18.1K, which are smaller than Movano, Inc. quarterly revenues of $80K. Nexalin Technology, Inc.'s net income of -$2.3M is higher than Movano, Inc.'s net income of -$4M. Notably, Nexalin Technology, Inc.'s price-to-earnings ratio is -- while Movano, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nexalin Technology, Inc. is 77.14x versus 11.44x for Movano, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NXLNexalin Technology, Inc.77.14x -- $18.1K -$2.3M MOVEMovano, Inc.11.44x -- $80K -$4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Sell
49
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
55
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
35
SMX alert for Dec 19
SMX (Security Matters) Plc [SMX] is up 11.91% over the past day.
Sell
36
INSP alert for Dec 19
Inspire Medical Systems, Inc. [INSP] is up 1.39% over the past day.
Sell
40
INSM alert for Dec 19
Insmed, Inc. [INSM] is up 4.79% over the past day.
